Table 2.
Associations between growth, body composition and IGF-1/IGFBP-3 Levels in VLBW Infants.
| Time | β (95% CI) | p-value | Time | β (95% CI) | p-value | ||
|---|---|---|---|---|---|---|---|
| Growth | Birth weight, z-score | ||||||
| DOL 7 | 1.99 (−0.92, 4.91) | 0.177 | DOL 7 | 0.05 (−0.04, 0.14) | 0.272 | ||
| 35 weeks PMA | 0.39 (−4.33, 5.11) | 0.869 | 35 weeks PMA | 0.07 (−0.04, 0.19) | 0.215 | ||
| Birth length, z-score | |||||||
| DOL 7 | 1.42 (−0.85, 3.7) | 0.215 | DOL 7 | 0.04 (−0.03, 0.11) | 0.230 | ||
| 35 weeks PMA | 2.81 (−0.59, 6.21) | 0.103 | 35 weeks PMA | 0.11 (0.02, 0.2) | 0.014 | ||
| Weight at discharge, z-score | |||||||
| DOL 7 | 0.3 (0, 0.06) | 0.086 | DOL 7 | 0.74 (−0.77, 2.25) | 0.326 | ||
| 35 weeks PMA | 0.01 (−0.02, 0.03) | 0.433 | 35 weeks PMA | 0.75 (−0.13, 1.62) | 0.091 | ||
| Length at discharge, z-score | |||||||
| DOL 7 | 0.03 (−0.01, 0.06) | 0.106 | DOL 7 | 1.41 (−0.16, 2.99) | 0.078 | ||
| 35 weeks PMA | 0.01 (−0.01, 0.04) | 0.271 | 35 weeks PMA | 1.1 (0.17, 2.03) | 0.022 | ||
| OFC at discharge, z-score | |||||||
| DOL 7 | 0.02 (−0.01, 0.05) | 0.231 | DOL 7 | 0.69 (−0.81, 2.2) | 0.358 | ||
| 35 weeks PMA | 0 (−0.03, 0.02) | 0.755 | 35 weeks PMA | −0.02 (−0.96, 0.91) | 0.959 | ||
| Body Composition | Fat mass at discharge, z-score | ||||||
| DOL 7 | 0.07 (0, 0.15) | 0.053 | DOL 7 | 0.59 (−2.74, 3.92) | 0.722 | ||
| 35 weeks PMA | 0.03 (−0.03, 0.08) | 0.329 | 35 weeks PMA | 0.87 (−1, 2.75) | 0.352 | ||
| Fat free mass at discharge, z-score | |||||||
| DOL 7 | 0.03 (−0.02, 0.07) | 0.200 | DOL 7 | 1.44 (−0.45, 3.32) | 0.131 | ||
| 35 weeks PMA | 0.01 (−0.02, 0.04) | 0.451 | 35 weeks PMA | 1 (−0.07, 2.08) | 0.066 | ||
| Percent body fat at discharge, % | |||||||
| DOL 7 | 0.03 (−0.04, 0.1) | 0.464 | DOL 7 | 0.3 (−2.75, 3.34) | 0.844 | ||
| 35 weeks PMA | 0.02 (−0.03, 0.06) | 0.494 | 35 weeks PMA | 0.35 (−1.34, 2.04) | 0.677 | ||
| IGF-1/IGFBP-3 Levels | Early IGF-1 | ||||||
| DOL 7 | 0.01 (0.01, 0.02) | <0.001 | |||||
| 35 weeks PMA | 0.1 (−0.36, 0.55) | 0.676 | 35 weeks PMA | 0.01 (0, 0.02) | 0.126 | ||
| Early IGFBP-3 | |||||||
| DOL 7 | 0.01 (0.01, 0.02) | <0.001 | |||||
| 35 weeks PMA | 19.07 (7.73, 30.41) | 0.001 | 35 weeks PMA | 0.56 (0.28, 0.84) | <0.001 |
All variables were studied separately and adjusted for birth gestational age, PMA at DOL 7/35 weeks, sex, and study arm (intervention vs control).
DOL Day of life, PMA Postmenstrual age.